• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能否根据全身免疫炎症指数来确定骨关节炎的严重程度?

Can We Determine Osteoarthritis Severity Based on Systemic Immuno-Inflammatory Index?

作者信息

Yilmaz Bilge Kagan, Altin Recep, Sari Alper

机构信息

Department of Orthopaedic and Traumatology, Afyonkarahisar Health Science University, 03030 Afyonkarahisar, Turkey.

Department of Internal Medicine, Afyonkarahisar Health Science University, 03030 Afyonkarahisar, Turkey.

出版信息

Diagnostics (Basel). 2025 Jun 18;15(12):1556. doi: 10.3390/diagnostics15121556.

DOI:10.3390/diagnostics15121556
PMID:40564880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192534/
Abstract

Osteoarthritis (OA) is one of the common joint diseases. Hematologic markers have been investigated to determine its severity and predict the prognosis of joint diseases. In this study, we investigated whether the systemic immune-inflammatory index (SII) is a marker for assessing the severity of OA. : The records of patients diagnosed with OA at various stages between 1 January 2020 and 1 January 2022 were retrospectively analyzed. Patients aged 18-75 years with complete blood count within the last 15 days and not taking anti-inflammatory drugs were included in the study. Patients were classified according to the Kellgren-Lawrance classification as stage 1-2-3 mild to moderate OA (Group I) and stage 4 severe OA (Group II). A total of 1580 patients were diagnosed with knee OA and 946 were included in the study. Of the patients, 246 (26%) were male and 700 (74%) were female. The mean age of the patients was 61.00 (53.00-68.00) years. : There were 449 (47.5%) patients in Group I and 497 (52.5%) patients in Group II. Statistically significant differences were found between the groups in age, gender, hemoglobin, lymphocytes, and SII ( < 0.05). An SII value of 627.9 was found to distinguish severe OA from mild-moderate OA with 42.5% sensitivity and 70.6% specificity. : Although this study is the first in the literature, it shows that SII has limited predictive value in assessing the severity of knee OA. Future research should focus on longitudinal studies to establish causality and explore therapeutic implications.

摘要

骨关节炎(OA)是常见的关节疾病之一。人们已经对血液学标志物进行了研究,以确定其严重程度并预测关节疾病的预后。在本研究中,我们调查了全身免疫炎症指数(SII)是否为评估OA严重程度的标志物。:回顾性分析了2020年1月1日至2022年1月1日期间不同阶段诊断为OA的患者记录。纳入研究的患者年龄在18 - 75岁之间,在过去15天内进行过全血细胞计数且未服用抗炎药物。根据凯尔格伦 - 劳伦斯分类法,患者被分为1 - 2 - 3期轻度至中度OA(第一组)和4期重度OA(第二组)。共有1580例患者被诊断为膝骨关节炎,946例纳入研究。其中,男性246例(26%),女性700例(74%)。患者的平均年龄为61.00(53.00 - 68.00)岁。:第一组有449例(47.5%)患者,第二组有497例(52.5%)患者。两组在年龄、性别、血红蛋白、淋巴细胞和SII方面存在统计学显著差异(<0.05)。发现SII值为627.9时,区分重度OA与轻度至中度OA的敏感性为42.5%,特异性为70.6%。:尽管本研究在文献中尚属首次,但表明SII在评估膝骨关节炎严重程度方面的预测价值有限。未来的研究应侧重于纵向研究以确定因果关系并探索治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a9/12192534/167563c3efcd/diagnostics-15-01556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a9/12192534/167563c3efcd/diagnostics-15-01556-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1a9/12192534/167563c3efcd/diagnostics-15-01556-g001.jpg

相似文献

1
Can We Determine Osteoarthritis Severity Based on Systemic Immuno-Inflammatory Index?我们能否根据全身免疫炎症指数来确定骨关节炎的严重程度?
Diagnostics (Basel). 2025 Jun 18;15(12):1556. doi: 10.3390/diagnostics15121556.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.撤回:用于治疗膝关节骨关节炎的非阿司匹林非甾体抗炎药。
Cochrane Database Syst Rev. 2007 Jul 18;2006(1):CD000142. doi: 10.1002/14651858.CD000142.pub2.
6
Is Kinesiophobia Associated With Quality of Life, Level of Physical Activity, and Function in Older Adults With Knee Osteoarthritis?恐动症与老年膝骨关节炎患者的生活质量、身体活动水平及功能是否相关?
Clin Orthop Relat Res. 2025 Apr 1;483(4):667-676. doi: 10.1097/CORR.0000000000003278. Epub 2024 Oct 9.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
8
Celecoxib for osteoarthritis.塞来昔布用于骨关节炎
Cochrane Database Syst Rev. 2017 May 22;5(5):CD009865. doi: 10.1002/14651858.CD009865.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) to predict postoperative pneumonia in elderly hip fracture patients.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和全身免疫炎症指数(SII)预测老年髋部骨折患者术后肺炎。
J Orthop Surg Res. 2023 Sep 12;18(1):673. doi: 10.1186/s13018-023-04157-x.
2
Correlation between Inflammatory Systemic Biomarkers and Surgical Trauma in Elderly Patients with Hip Fractures.老年髋部骨折患者炎症系统生物标志物与手术创伤的相关性
J Clin Med. 2023 Aug 6;12(15):5147. doi: 10.3390/jcm12155147.
3
Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults.
全身免疫炎症指数(SII)、系统炎症反应指数(SIRI)与全因死亡率及心血管死亡率风险:一项对42875名美国成年人的20年随访队列研究
J Clin Med. 2023 Jan 31;12(3):1128. doi: 10.3390/jcm12031128.
4
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis.全身免疫炎症指数预测癌症免疫治疗的预后:系统评价与荟萃分析
Immunotherapy. 2022 Dec;14(18):1481-1496. doi: 10.2217/imt-2022-0133. Epub 2022 Dec 20.
5
Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease.全身免疫炎症指数与动脉粥样硬化性心血管疾病患者全因死亡率的关联
Front Cardiovasc Med. 2022 Sep 12;9:952953. doi: 10.3389/fcvm.2022.952953. eCollection 2022.
6
Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019.1990 年至 2019 年特定部位骨关节炎的流行趋势:2019 年全球疾病负担研究的结果。
Arthritis Rheumatol. 2022 Jul;74(7):1172-1183. doi: 10.1002/art.42089. Epub 2022 Jun 2.
7
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.术后全身免疫炎症指数(SII):子宫内膜癌的一个优越预后因素。
Front Surg. 2021 Oct 22;8:704235. doi: 10.3389/fsurg.2021.704235. eCollection 2021.
8
Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19.恶性肿瘤住院患者全身免疫炎症指数(SII)、预警评分(ANDC)和预后营养指数(PNI)的比较及其对COVID-19死亡率的影响。
Infect Agent Cancer. 2021 Sep 15;16(1):60. doi: 10.1186/s13027-021-00400-4.
9
Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis.系统性免疫炎症指数与强直性脊柱炎患者的疾病活动度相关。
J Clin Lab Anal. 2021 Sep;35(9):e23964. doi: 10.1002/jcla.23964. Epub 2021 Aug 21.
10
Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: a prospective cohort study.系统免疫炎症指数独立预测老年髋部骨折患者预后不良:一项前瞻性队列研究。
BMC Geriatr. 2021 Mar 4;21(1):155. doi: 10.1186/s12877-021-02102-3.